{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,19]],"date-time":"2025-04-19T04:17:21Z","timestamp":1745036241410},"reference-count":17,"publisher":"Japanese Society of Internal Medicine","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2022,1,1]]},"DOI":"10.2169\/internalmedicine.7531-21","type":"journal-article","created":{"date-parts":[[2021,6,25]],"date-time":"2021-06-25T22:07:12Z","timestamp":1624658832000},"page":"87-90","source":"Crossref","is-referenced-by-count":2,"title":["Development of Intravascular Large B-cell Lymphoma during Methotrexate Treatment for Rheumatoid Arthritis"],"prefix":"10.2169","volume":"61","author":[{"given":"Tomohisa","family":"Tabuchi","sequence":"first","affiliation":[{"name":"Department of Hematology, Imakiire General Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hirosaka","family":"Inoue","sequence":"additional","affiliation":[{"name":"Department of Hematology, Imakiire General Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kosuke","family":"Obama","sequence":"additional","affiliation":[{"name":"Department of Hematology, Imakiire General Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Hashimoto A, Chiba N, Tsuno H, et al. Incidence of malignancy and the risk of lymphoma in Japanese patients with rheumatoid arthritis compared to the general population. J Rheumatol 42: 564-571, 2015.","DOI":"10.3899\/jrheum.140533"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Kamel OW, Van de RM, Weiss LM, et al. Brief report: reversible lymphomas associated with Epstein-Barr virus occurring during methotrexate therapy for rheumatoid arthritis and dermatomyositis. N Engl J Med 328: 1317-1321, 1993.","DOI":"10.1056\/NEJM199305063281806"},{"key":"3","unstructured":"3. Gaulard P, Swerdlow SH, Harris NL, Sundstrom C, Jaffe ES. Other iatrogenic immunodeficiency-associated lymphoproliferative disorders. In: WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. Revised 4th ed. Swerdlow SH, Campo E, Harris NL, et al., Eds. IARC Press, Lyon, 2017: 462-464."},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Honda S, Sakai R, Inoue E, et al. Association of methotrexate use and lymphoproliferative disorder in patients with rheumatoid arthritis: results from a Japanese multi-institutional retrospective study. Mod Rheumatol 11: 1-20, 2021.","DOI":"10.1080\/14397595.2020.1869370"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Kikuchi J, Kaneko Y, Kasahara H, et al. Methotrexate-associated intravascular large B-cell lymphoma in a patient with rheumatoid arthritis. Intern Med 55: 1661-1665, 2016.","DOI":"10.2169\/internalmedicine.55.6943"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Iwami E, Ito F, Sasahara K, et al. Pulmonary intravascular large B-cell lymphoma in a patient administered methotrexate for rheumatoid arthritis. Intern Med 59: 429-433, 2020.","DOI":"10.2169\/internalmedicine.3216-19"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Hagihara M, Mese T, Ohara S, Hua J, Ide S, Inoue M. Methotrexate-associated intravascular large B-cell lymphoma in a patient with rheumatoid arthritis: a very rare case. Intern Med 57: 3001-3005, 2018.","DOI":"10.2169\/internalmedicine.0875-18"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Kida T, Kohno M, Chinen Y, et al. Intravascular lymphoma in a rheumatoid arthritis patient following short-term methotrexate treatment. Rheumatology (Oxford) 56: 318-320, 2017.","DOI":"10.1093\/rheumatology\/kew414"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Komeno Y, Akiyama M, Okochi Y, et al. Hemophagocytic syndrome-associated intravascular large B-cell lymphoma in a rheumatoid arthritis patient. Case Rep Hematol 2019: 8947616, 2019.","DOI":"10.1155\/2019\/8947616"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Colavolpe C, Ebbo M, Trousse D, et al. FDG-PET\/CT is a pivotal imaging modality to diagnose rare intravascular large B-cell lymphoma: case report and review of literature. Hematol Oncol 33: 99-109, 2015.","DOI":"10.1002\/hon.2140"},{"key":"11","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1182\/blood-2006-01-021253","volume":"109","author":"T Murase","year":"2007","unstructured":"11. Murase T, Yamaguchi M, Suzuki R, et al. Intravascular large B-cell lymphoma (IVLBCL): a clinicopathologic study of 96 cases with special reference to the immunophenotypic heterogeneity of CD5. Blood 109: 478-485, 2007.","journal-title":"Blood","ISSN":"http:\/\/id.crossref.org\/issn\/0006-4971","issn-type":"print"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Murase T, Nakamura S, Kawauchi K, et al. An Asian variant of intravascular large B-cell lymphoma: clinical, pathological and cytogenetic approaches to diffuse large B-cell lymphoma associated with haemophagocytic syndrome. Br J Haematol 111: 826-834, 2000.","DOI":"10.1111\/j.1365-2141.2000.02426.x"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Inui Y, Matsuoka H, Yakushijin K, et al. Methotrexate-associated lymphoproliferative disorders: management by watchful waiting and observation of early lymphocyte recovery after methotrexate withdrawal. Leuk Lymphoma 56: 3045-3051, 2015.","DOI":"10.3109\/10428194.2015.1022769"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Saito S, Kaneko Y, Yamaoka K, Tokuhira M, Takeuchi T. Distinct patterns of lymphocyte count transition in lymphoproliferative disorders in patients with rheumatoid arthritis treated with methotrexate. Rheumatology (Oxford) 56: 940-946, 2017.","DOI":"10.1093\/rheumatology\/kex002"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Bruce NC, Thomas MA. Methotrexate and its mechanisms of action in inflammatory arthritis. Nat Rev Rheumatol 16: 145-154, 2020.","DOI":"10.1038\/s41584-020-0373-9"},{"key":"16","unstructured":"16. Bleyer WA. Methotrexate induced lymphoma? J Rheumatol 25: 404-407, 1998."},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Saito S, Suzuki K, Yoshimoto K, et al. Restoration of decreased T helper 1 and CD8+ T cell subsets is associated with regression of lymphoproliferative disorders developed during methotrexate treatment. Front Immunol 9: 621, 2018.","DOI":"10.3389\/fimmu.2018.00621"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/61\/1\/61_7531-21\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T03:31:39Z","timestamp":1641007899000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/61\/1\/61_7531-21\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,1]]},"references-count":17,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.7531-21","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,1]]},"article-number":"7531-21"}}